MCB Seminar | Benefits and Drawbacks of Drug Combinations in Cancer Treatment, March 30
The Molecular and Cellular Biology Seminar series features Emily Davis discussing “The Benefits and Drawbacks of Drug Combinations in Cancer Treatment” on March 30 from 4:35 to 5:55 p.m. Contact Dr. Sarah Wyatt, MCB director, for Teams information. Davis is a graduate student in Biological Sciences at Ohio University and […]
Read more ›
Comments